Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Novo Nordisk stock in Canada
Novo Nordisk stock has moved 0.81% from yesterday's closing price. Learn how to easily invest in Novo Nordisk stock.
Novo Nordisk is a biotechnology business based in the US. Novo Nordisk stocks (NVO.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $117.83 – an increase of 3.87% over the previous week. Novo Nordisk employs 52,696 staff and has a trailing 12-month revenue of around $167.2 billion.
How to buy Novo Nordisk stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – NVO. It's that simple.
What's in this guide?
- Can I buy shares in Novo Nordisk?
- Has coronavirus impacted Novo Nordisk shares?
- Novo Nordisk shares summary
- Compare share dealing platforms
- Is Novo Nordisk stock a buy or sell?
- Novo Nordisk performance over time
- Are Novo Nordisk shares over-valued?
- Novo Nordisk's financials
- How volatile are Novo Nordisk shares?
- Does Novo Nordisk pay a dividend?
- Have Novo Nordisk shares ever split?
- Other common questions
Novo Nordisk stock price (NYSE:NVO)Use our graph to track the performance of NVO stocks over time.
Novo Nordisk shares at a glance
|Latest market close||$117.83|
|52-week range||$90.40 - $121.50|
|50-day moving average||$106.36|
|200-day moving average||$108.11|
|Wall St. target price||$126.84|
|Dividend yield||$11.15 (1.41%)|
|Earnings per share (TTM)||$3.23|
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Novo Nordisk stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Novo Nordisk price performance over time
|1 week (2022-11-18)||3.87%|
|1 month (2022-10-26)||9.29%|
|3 months (2022-08-26)||8.41%|
|6 months (2022-05-26)||10.53%|
|1 year (2021-11-26)||8.93%|
|2 years (2020-11-25)||78.15%|
|3 years (2019-11-26)||109.48%|
|5 years (2017-11-24)||125.56%|
Is Novo Nordisk under- or over-valued?
Valuing Novo Nordisk stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Novo Nordisk's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Novo Nordisk's P/E ratio
Novo Nordisk's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 36x. In other words, Novo Nordisk shares trade at around 36x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Novo Nordisk's PEG ratio
Novo Nordisk's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7439. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Novo Nordisk's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Novo Nordisk's EBITDA
Novo Nordisk's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $77.6 billion.
The EBITDA is a measure of a Novo Nordisk's overall financial performance and is widely used to measure a its profitability.
Novo Nordisk financials
|Revenue TTM||$167.2 billion|
|Operating margin TTM||43.1%|
|Gross profit TTM||$117.1 billion|
|Return on assets TTM||21.6%|
|Return on equity TTM||73.99%|
|Market capitalisation||$259.4 billion|
TTM: trailing 12 months
Novo Nordisk share dividends
Dividend payout ratio: 6.9% of net profits
Recently Novo Nordisk has paid out, on average, around 6.9% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.41% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Novo Nordisk shareholders could enjoy a 1.41% return on their shares, in the form of dividend payments. In Novo Nordisk's case, that would currently equate to about $11.15 per share.
While Novo Nordisk's payout ratio might seem low, this can signify that Novo Nordisk is investing more in its future growth.
Novo Nordisk's most recent dividend payout was on 23 August 2022. The latest dividend was paid out to all shareholders who bought their shares by 12 August 2022 (the "ex-dividend date").
Have Novo Nordisk's shares ever split?
Novo Nordisk's shares were split on a 5:1 basis on 9 January 2014. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Novo Nordisk shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Novo Nordisk shares which in turn could have impacted Novo Nordisk's share price.
Novo Nordisk share price volatility
Over the last 12 months, Novo Nordisk's shares have ranged in value from as little as $90.4 up to $121.5047. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Novo Nordisk's is 0.3235. This would suggest that Novo Nordisk's shares are less volatile than average (for this exchange).
Novo Nordisk overview
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease.
Stocks similar to Novo Nordisk
Novo Nordisk in the news
Should You Invest in Novo Nordisk A/S (NVO) Stock?
3 Healthcare Stocks That Could Set You Up For Life
15 Biggest European Pharmaceutical Companies
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
Market volatility can be nerve-wracking. Discover 3 trading strategies plus the pros, cons and risks of investing in volatile markets.Read more…
Find out the key differences between the Dow Jones and S&P 500 plus key points to consider before investing.Read more…
Find out how long term investments work and how to use long term investments to build your wealth.Read more…
More guides on Finder
3 strategies for investing in volatile markets
Market volatility can be nerve-wracking. Discover 3 trading strategies plus the pros, cons and risks of investing in volatile markets.
FTSE 100 vs Dow Jones
Find out the key differences between the FTSE 100 and Dow Jones plus key points to consider before investing.
How to buy Africa Oil stock in Canada
Steps to owning and managing AOI stock, with 24-hour and historical pricing before you buy.
How to buy CES Energy Solutions stock in Canada
Steps to owning and managing ARBK stock, with 24-hour and historical pricing before you buy.
Dow Jones vs S&P 500
Find out the key differences between the Dow Jones and S&P 500 plus key points to consider before investing.
FTSE 250 vs S&P 500
Find out the key differences between the FTSE 250 and the S&P 500.
How to buy Kraken Robotics stock in Canada
Steps to owning and managing PNG stock, with 24-hour and historical pricing before you buy.
Finder Stock Trading Platform Awards 2022
We narrowed down the best stock trading platforms based on 9 different categories. See how your brokerage stacks up.
How to buy CBL International Limited (BANL) stock in Canada when it goes public
Everything we know about the CBL International Limited IPO plus information on how to buy in.
How to buy Infinite Group (IMCI) stock in Canada when it goes public
Everything we know about the Infinite Group IPO plus information on how to buy in.
Ask an Expert
You must be logged in to post a comment.